Identifier
Created
Classification
Origin
06OTTAWA40
2006-01-06 17:16:00
UNCLASSIFIED
Embassy Ottawa
Cable title:
WHO EXECUTIVE BOARD: DEMARCHE REQUEST ON SMALLPOX
how-toThis record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS OTTAWA 000040
SIPDIS
E.O. 12958: N/A
TAGS: PREL AORC TBIO CA WHO
SUBJECT: WHO EXECUTIVE BOARD: DEMARCHE REQUEST ON SMALLPOX
AGENDA ITEM
REF: SECSTATE 232766
ESTH Counselor made the demarche requested in reftel to
senior health and foreign affair officials in the Canadian
Government, including Senior Asst. Deputy Minister of Health,
Ian Shugart, Director General for International Affairs at
Health Canada, Carla Gilders, and Senior Policy Advisor for
International Health Affairs at Foreign Affairs Canada, Don
MacPhee. Gilders told us that the GOC was sympathetic to our
concerns. The GOC would like to see the eventual destruction
of smallpox virus stocks in the U.S. and Russia, but
understands the need for continued research for the
development of antiviral drugs and vaccines. Her comments
were echoed by Don MacPhee, who represented Canada in Geneva
on WHO issues prior to his reassignment to Ottawa. Both said
that there would be a Canadian delegation meeting in Ottawa
next week to prepare for the upcoming WHO Executive Board
meeting and noted that the U.S. demarche would be discussed
at that time. Post will report any additional information we
may be able to get on the GOC's position prior to the
Executive Board meeting later this month.
Visit Canada's Classified Web Site at
http://www.state.sgov.gov/p/wha/ottawa
WILKINS
SIPDIS
E.O. 12958: N/A
TAGS: PREL AORC TBIO CA WHO
SUBJECT: WHO EXECUTIVE BOARD: DEMARCHE REQUEST ON SMALLPOX
AGENDA ITEM
REF: SECSTATE 232766
ESTH Counselor made the demarche requested in reftel to
senior health and foreign affair officials in the Canadian
Government, including Senior Asst. Deputy Minister of Health,
Ian Shugart, Director General for International Affairs at
Health Canada, Carla Gilders, and Senior Policy Advisor for
International Health Affairs at Foreign Affairs Canada, Don
MacPhee. Gilders told us that the GOC was sympathetic to our
concerns. The GOC would like to see the eventual destruction
of smallpox virus stocks in the U.S. and Russia, but
understands the need for continued research for the
development of antiviral drugs and vaccines. Her comments
were echoed by Don MacPhee, who represented Canada in Geneva
on WHO issues prior to his reassignment to Ottawa. Both said
that there would be a Canadian delegation meeting in Ottawa
next week to prepare for the upcoming WHO Executive Board
meeting and noted that the U.S. demarche would be discussed
at that time. Post will report any additional information we
may be able to get on the GOC's position prior to the
Executive Board meeting later this month.
Visit Canada's Classified Web Site at
http://www.state.sgov.gov/p/wha/ottawa
WILKINS